Peer Review reports
From: Targeting PCSK9 to upregulate MHC-II on the surface of tumor cells in tumor immunotherapy
| Original Submission | ||
|---|---|---|
| 12 Oct 2023 | Submitted | Original manuscript |
| 30 Oct 2023 | Reviewed | Reviewer Report |
| 9 Nov 2023 | Reviewed | Reviewer Report |
| 21 Jan 2024 | Author responded | Author comments - Jia Wei |
| Resubmission - Version 2 | ||
| 21 Jan 2024 | Submitted | Manuscript version 2 |
| 24 Jan 2024 | Author responded | Author comments - Jia Wei |
| Resubmission - Version 3 | ||
| 24 Jan 2024 | Submitted | Manuscript version 3 |
| 26 Jan 2024 | Author responded | Author comments - Jia Wei |
| Resubmission - Version 4 | ||
| 26 Jan 2024 | Submitted | Manuscript version 4 |
| 7 Feb 2024 | Reviewed | Reviewer Report |
| 9 Feb 2024 | Reviewed | Reviewer Report |
| 17 Feb 2024 | Author responded | Author comments - Jia Wei |
| Resubmission - Version 5 | ||
| 17 Feb 2024 | Submitted | Manuscript version 5 |
| 23 Feb 2024 | Author responded | Author comments - Jia Wei |
| Resubmission - Version 6 | ||
| 23 Feb 2024 | Submitted | Manuscript version 6 |
| 12 Mar 2024 | Reviewed | Reviewer Report |
| 18 Mar 2024 | Reviewed | Reviewer Report |
| 19 Mar 2024 | Author responded | Author comments - Jia Wei |
| Resubmission - Version 7 | ||
| 19 Mar 2024 | Submitted | Manuscript version 7 |
| Publishing | ||
| 20 Mar 2024 | Editorially accepted | |
| 10 Apr 2024 | Article published | 10.1186/s12885-024-12148-2 |
You can find further information about peer review here.